Related references
Note: Only part of the references are listed.Intellectual, educational, and situation-based social outcome in adult survivors of childhood medulloblastoma
Virginie Kieffer et al.
DEVELOPMENTAL NEUROREHABILITATION (2019)
Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
Catherine Lee et al.
NATURE COMMUNICATIONS (2019)
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)
Dagmar Beier et al.
NEURO-ONCOLOGY (2018)
Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas
Ji Hoon Phi et al.
ACTA NEUROPATHOLOGICA (2018)
M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas
Chanhee Lee et al.
BMC CANCER (2018)
Development of a pre-operative scoring system for predicting risk o f post-operative paediatric cerebellar mutism syndrome
Jo-Fen Liu et al.
BRITISH JOURNAL OF NEUROSURGERY (2018)
Left Hippocampal Dosimetry Correlates With Visual and Verbal Memory Outcomes in Survivors of Pediatric Brain Tumors
Andrew H. Zureick et al.
CANCER (2018)
NRL and CRX Define Photoreceptor Identity and Reveal Subgroup-Specific Dependencies in Medulloblastoma
Alexandra Garancher et al.
CANCER CELL (2018)
A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases (vol 172, pg 1050, 2018)
Livia Garzia et al.
CELL (2018)
Development of Potent Pyrazolopyrimidinone-Based WEE1 Inhibitors with Limited Single-Agent Cytotoxicity for Cancer Therapy
Christopher J. Matheson et al.
CHEMMEDCHEM (2018)
Diagnostic challenges in a child with early onset desmoplastic medulloblastoma and homozygous variants in MSH2 and MSH6
Julia Taeubner et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2018)
Cognitive and Adaptive Outcomes After Proton Radiation for Pediatric Patients With Brain Tumors
Margaret B. Pulsifer et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors
Michelle S. Gentile et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
The clinical importance of medulloblastoma extent of resection: a systematic review
Eric M. Thompson et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Survival Following Tumor Recurrence in Children With Medulloblastoma
Donna L. Johnston et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2018)
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort
Sebastian M. Waszak et al.
LANCET ONCOLOGY (2018)
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial
Giles W. Robinson et al.
LANCET ONCOLOGY (2018)
DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience
Banu Atalar et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Subgroup-specific immune and stromal microenvironment in medulloblastoma
Michael Bockmayr et al.
ONCOIMMUNOLOGY (2018)
Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells
Anandani Nellan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling
Antoine Forget et al.
CANCER CELL (2018)
Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups
Tenley C. Archer et al.
CANCER CELL (2018)
Identifying drivers of SMARCA4/BRG1-deficient SCCOHT tumorigenesis by integrative multi-omic analysis
Krystal A. Orlando et al.
CANCER RESEARCH (2018)
Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors
Ralph E. Vatner et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group
Stefan Rutkowski et al.
LANCET ONCOLOGY (2018)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2018)
Therapeutic potential of targeting the Eph/ephrin signaling complex
Nayanendu Saha et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Executive function in paediatric medulloblastoma: The role of cerebrocerebellar connections
Nicole Law et al.
JOURNAL OF NEUROPSYCHOLOGY (2017)
Molecular pathology of paediatric central nervous system tumours
Jason C. H. Chiang et al.
JOURNAL OF PATHOLOGY (2017)
Smaller hippocampal subfield volumes predict verbal associative memory in pediatric brain tumor survivors
Alexandra L. Decker et al.
HIPPOCAMPUS (2017)
Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream
Stephen C. Mack et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013
Vishesh Khanna et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
Edward C. Schwalbe et al.
LANCET ONCOLOGY (2017)
The whole-genome landscape of medulloblastoma subtypes
Paul A. Northcott et al.
NATURE (2017)
Disrupted development and integrity of frontal white matter in patients treated for pediatric medulloblastoma
John O. Glass et al.
NEURO-ONCOLOGY (2017)
Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study
Jane E. Schreiber et al.
NEURO-ONCOLOGY (2017)
Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells
D. Kawauchi et al.
ONCOGENE (2017)
Attention, processing speed, and executive functioning in pediatric brain tumor survivors treated with proton beam radiation therapy
Tanya N. Antonini et al.
RADIOTHERAPY AND ONCOLOGY (2017)
OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma
Gaylor Boulay et al.
CANCER DISCOVERY (2017)
Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression
Gregorio J. Petrirena et al.
Oncotarget (2017)
Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor
Giles W. Robinson et al.
ONCOTARGET (2017)
Minimal methylation classifier (MIMIC): A novel method for derivation and rapid diagnostic detection of disease-associated DNA methylation signatures
E. C. Schwalbe et al.
SCIENTIFIC REPORTS (2017)
DNA-methylation profiling discloses significant advantages over NanoString method for molecular classification of medulloblastoma
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2017)
Quality of life in long-term survivors treated for metastatic medulloblastoma with a hyperfractionated accelerated radiotherapy (HART) strategy
L. Veneroni et al.
CHILDS NERVOUS SYSTEM (2017)
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome
Pooja Panwalkar et al.
ACTA NEUROPATHOLOGICA (2017)
Inhibition of CDK4/6 by Palbociclib Significantly Extends Survival in Medulloblastoma Patient-Derived Xenograft Mouse Models
Michelle L. Cook Sangar et al.
CLINICAL CANCER RESEARCH (2017)
Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome
William D. Foulkes et al.
CLINICAL CANCER RESEARCH (2017)
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Florence M. G. Cavalli et al.
CANCER CELL (2017)
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome
Christian P. Kratz et al.
CLINICAL CANCER RESEARCH (2017)
Pediatric brain tumors in a low/middle income country: does it differ from that in developed world?
Sameera Ezzat et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation
A-S Tigan et al.
ONCOGENE (2016)
Targeting CDK4 and CDK6: From Discovery to Therapy
Charles J. Sherr et al.
CANCER DISCOVERY (2016)
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
Vijay Ramaswamy et al.
ACTA NEUROPATHOLOGICA (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
A Recurrent Mosaic Mutation in SMO, Encoding the Hedgehog Signal Transducer Smoothened, Is the Major Cause of Curry-Jones Syndrome
Stephen R. F. Twigg et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma
Yanxin Pei et al.
CANCER CELL (2016)
Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype
Timothy N. Phoenix et al.
CANCER CELL (2016)
Consensus paper on post-operative pediatric cerebellar mutism syndrome: the Iceland Delphi results
Thora Gudrunardottir et al.
CHILDS NERVOUS SYSTEM (2016)
DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets
Allison R. Hanaford et al.
CLINICAL CANCER RESEARCH (2016)
Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury
Drosoula Giantsoudi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Results of COG ACNS0331: A Phase III Trial of Involved-Field Radiotherapy (IFRT) and Low Dose Craniospinal Irradiation (LD-CSI) with Chemotherapy in Average-Risk Medulloblastoma: A Report from the Children's Oncology Group
J. M. Michalski et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Intellectual Outcome in Molecular Subgroups of Medulloblastoma
Iska Moxon-Emre et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters
Andre O. von Bueren et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors
Lisa S. Kahalley et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Neurocognitive Function and Health-Related Quality of Life in Pediatric Korean Survivors of Medulloblastoma
Hee Jung Yoo et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study
Magnus Sabel et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma
Iska Moxon-Emre et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2016)
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
Eric M. Thompson et al.
LANCET ONCOLOGY (2016)
Long-term toxic eff ects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study
Torunn I. Yock et al.
LANCET ONCOLOGY (2016)
Divergent clonal selection dominates medulloblastoma at recurrence
A. Sorana Morrissy et al.
NATURE (2016)
Active medulloblastoma enhancers reveal subgroup-specific cellular origins
Charles Y. Lin et al.
NATURE (2016)
White Matter and Information Processing Speed Following Treatment With Cranial-Spinal Radiation for Pediatric Brain Tumor
Nadia Scantlebury et al.
NEUROPSYCHOLOGY (2016)
Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy
Lucie Lafay-Cousin et al.
PEDIATRIC BLOOD & CANCER (2016)
Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma
Eric W. Prince et al.
ONCOTARGET (2016)
Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease
Rebecca M. Hill et al.
CANCER CELL (2015)
Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy
Hugo Camara-Costa et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
White and Gray Matter Abnormalities After Cranial Radiation in Children and Mice
Brian J. Nieman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032
Giles W. Robinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Computerized Cognitive Training for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors: A Randomized Controlled Trial
Heather M. Conklin et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Molecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumours
T. Goschzik et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)
Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastoma
Claudia C. Faria et al.
ONCOTARGET (2015)
Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial
Steven C. Clifford et al.
ONCOTARGET (2015)
Tumor-Associated Macrophages in SHH Subgroup of Medulloblastomas
Ashley S. Margol et al.
CLINICAL CANCER RESEARCH (2015)
TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours
Janet C. Lindsey et al.
ACTA NEUROPATHOLOGICA (2014)
Improved health-related quality of life outcomes associated with SHH subgroup medulloblastoma in SIOP-UKCCSG PNET3 trial survivors
Kim S. Bull et al.
ACTA NEUROPATHOLOGICA (2014)
Genomic and transcriptomic analyses match medulloblastoma mouse models to their human counterparts
Julia Poeschl et al.
ACTA NEUROPATHOLOGICA (2014)
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity
Tara Spence et al.
ACTA NEUROPATHOLOGICA (2014)
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
Torsten Pietsch et al.
ACTA NEUROPATHOLOGICA (2014)
Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
Marcel Kool et al.
CANCER CELL (2014)
Vulnerabilities of Mutant SWI/SNF Complexes in Cancer
Katherine C. Helming et al.
CANCER CELL (2014)
Quiescent Sox2+ Cells Drive Hierarchical Growth and Relapse in Sonic Hedgehog Subgroup Medulloblastoma
Robert J. Vanner et al.
CANCER CELL (2014)
Pemetrexed and Gemcitabine as Combination Therapy for the Treatment of Group3 Medulloblastoma
Marie Morfouace et al.
CANCER CELL (2014)
Quality of Survival and Growth in Children and Young Adults in the PNET4 European Controlled Trial of Hyperfractionated Versus Conventional Radiation Therapy for Standard-Risk Medulloblastoma
Colin Kennedy et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Germline Mutations in SUFU Cause Gorlin Syndrome-Associated Childhood Medulloblastoma and Redefine the Risk Associated With PTCH1 Mutations
Miriam J. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Cytogenetic Prognostication Within Medulloblastoma Subgroups
David J. H. Shih et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Impact of Craniospinal Dose, Boost Volume, and Neurologic Complications on Intellectual Outcome in Patients With Medulloblastoma
Iska Moxon-Emre et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Incidence of medulloblastoma in Canadian children
Donna L. Johnston et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Changes to Memory Structures in Children Treated for Posterior Fossa Tumors
Lily Riggs et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2014)
Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma
Peter S. Harris et al.
MOLECULAR CANCER (2014)
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
Paul A. Northcott et al.
NATURE (2014)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
TRANSITIONING FROM GENOTYPES TO EPIGENOTYPES: WHY THE TIME HAS COME FOR MEDULLOBLASTOMA EPIGENOMICS
N. V. Batora et al.
NEUROSCIENCE (2014)
OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels
Jens Bunt et al.
ACTA NEUROPATHOLOGICA (2013)
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies
Edward C. Schwalbe et al.
ACTA NEUROPATHOLOGICA (2013)
Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays
Volker Hovestadt et al.
ACTA NEUROPATHOLOGICA (2013)
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Marc Remke et al.
ACTA NEUROPATHOLOGICA (2013)
Imaging Changes in Very Young Children with Brain Tumors Treated with Proton Therapy and Chemotherapy
N. D. Sabin et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2013)
The Role of Chromatin Remodeling in Medulloblastoma
David T. W. Jones et al.
BRAIN PATHOLOGY (2013)
Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study
Amar Gajjar et al.
CLINICAL CANCER RESEARCH (2013)
Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: A prospective observational multicentre study
Carsten Friedrich et al.
EUROPEAN JOURNAL OF CANCER (2013)
The homeobox gene Otx2 in development and disease
Francis Beby et al.
EXPERIMENTAL EYE RESEARCH (2013)
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma
Nataliya Zhukova et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Processing Speed, Attention, and Working Memory After Treatment for Medulloblastoma: An International, Prospective, and Longitudinal Study
Shawna L. Palmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Characterization of Distinct Immunophenotypes across Pediatric Brain Tumor Types
Andrea M. Griesinger et al.
JOURNAL OF IMMUNOLOGY (2013)
Dullard/Ctdnep1 Modulates WNT Signalling Activity for the Formation of Primordial Germ Cells in the Mouse Embryo
Satomi S. Tanaka et al.
PLOS ONE (2013)
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor et al.
ACTA NEUROPATHOLOGICA (2012)
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2012)
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Marcel Kool et al.
ACTA NEUROPATHOLOGICA (2012)
A Mouse Model of the Most Aggressive Subgroup of Human Medulloblastoma
Daisuke Kawauchi et al.
CANCER CELL (2012)
OTX2 Represses Myogenic and Neuronal Differentiation in Medulloblastoma Cells
Ren-Yuan Bai et al.
CANCER RESEARCH (2012)
Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations
Tobias Rausch et al.
CELL (2012)
Matching mice to malignancy: molecular subgroups and models of medulloblastoma
Jasmine Lau et al.
CHILDS NERVOUS SYSTEM (2012)
OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells
Jens Bunt et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study
Regina I. Jakacki et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial
Birgitta Lannering et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
High Frequency of Germline SUFU Mutations in Children With Desmoplastic/Nodular Medulloblastoma Younger Than 3 Years of Age
Laurence Brugieres et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Induction Chemotherapy and Conformal Radiation Therapy for Very Young Children With Nonmetastatic Medulloblastoma: Children's Oncology Group Study P9934
David M. Ashley et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A Distinct Smoothened Mutation Causes Severe Cerebellar Developmental Defects and Medulloblastoma in a Novel Transgenic Mouse Model
Joyoti Dey et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Trevor J. Pugh et al.
NATURE (2012)
Novel mutations target distinct subgroups of medulloblastoma
Giles Robinson et al.
NATURE (2012)
Dissecting the genomic complexity underlying medulloblastoma
David T. W. Jones et al.
NATURE (2012)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott et al.
NATURE (2012)
PI3K signalling: the path to discovery and understanding
Bart Vanhaesebroeck et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
The clinical implications of medulloblastoma subgroups
Paul A. Northcott et al.
NATURE REVIEWS NEUROLOGY (2012)
Antioxidant enzyme polymorphisms and neuropsychological outcomes in medulloblastoma survivors: a report from the Childhood Cancer Survivor Study
Julienne Brackett et al.
NEURO-ONCOLOGY (2012)
Clinical and neuroanatomical predictors of cerebellar mutism syndrome
Nicole Law et al.
NEURO-ONCOLOGY (2012)
Personalized mice: modelling the molecular heterogeneity of medulloblastoma
S. L. Markant et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2012)
Medulloblastomics: the end of the beginning
Paul A. Northcott et al.
NATURE REVIEWS CANCER (2012)
Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct
Paul A. Northcott et al.
ACTA NEUROPATHOLOGICA (2011)
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
David W. Ellison et al.
ACTA NEUROPATHOLOGICA (2011)
OUTCOME AND PROGNOSTIC FACTORS OF RADIATION THERAPY FOR MEDULLOBLASTOMA
Stefan Rieken et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Adult Medulloblastoma Comprises Three Major Molecular Variants
Marc Remke et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
Yoon-Jae Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables
David W. Ellison et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
TP53 Mutations in Favorable-Risk Wnt/Wingless-Subtype Medulloblastomas
Janet C. Lindsey et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Treatment of young children with localized medulloblastoma by chemotherapy alone: Results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology
Andre O. von Bueren et al.
NEURO-ONCOLOGY (2011)
The Genetic Landscape of the Childhood Cancer Medulloblastoma
D. Williams Parsons et al.
SCIENCE (2011)
Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2010)
Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease
David W. Ellison
ACTA NEUROPATHOLOGICA (2010)
Population-based epidemiological study of primary intracranial tumors in childhood
Keishi Makino et al.
CHILDS NERVOUS SYSTEM (2010)
Pleiotropic role for MYCN in medulloblastoma
Fredrik J. Swartling et al.
GENES & DEVELOPMENT (2010)
Survival and Prognostic Factors of Early Childhood Medulloblastoma: An International Meta-Analysis
Stefan Rutkowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
TP53 Mutation Is Frequently Associated With CTNNB1 Mutation or MYCN Amplification and Is Compatible With Long-Term Survival in Medulloblastoma
Elke Pfaff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Subtypes of medulloblastoma have distinct developmental origins
Paul Gibson et al.
NATURE (2010)
Genomics of medulloblastoma: from Giemsa-banding to next-generation sequencing in 20 years
Paul A. Northcott et al.
NEUROSURGICAL FOCUS (2010)
Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes
Stefan Pfister et al.
ACTA NEUROPATHOLOGICA (2009)
CK2 and its role in Wnt and NF-κB signaling: Linking development and cancer
I. Dominguez et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Hyperfractionated Accelerated Radiotherapy in the Milan Strategy for Metastatic Medulloblastoma
Lorenza Gandola et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics
Sarah Fattet et al.
JOURNAL OF PATHOLOGY (2009)
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
Paul A. Northcott et al.
NATURE GENETICS (2009)
Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma
Nadia Barahmani et al.
NEURO-ONCOLOGY (2009)
Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy
Stefan Rutkowski et al.
NEURO-ONCOLOGY (2009)
Brief Report: Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449.
Charles M. Rudin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2
James S. Duncan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma
Ulrich Schueller et al.
CANCER CELL (2008)
Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells
Zeng-Jie Yang et al.
CANCER CELL (2008)
The Smo/Smo model: Hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread
Beryl A. Hatton et al.
CANCER RESEARCH (2008)
Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal (posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy (for average-risk medulloblastoma
Thomas E. Merchant et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
PRDM6 is enriched in vascular precursors during development and inhibits endothelial cell proliferation, survival, and differentiation
Yaxu Wu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
Marcel Kool et al.
PLOS ONE (2008)
Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the Head Start I and II protocols
Girish Dhall et al.
PEDIATRIC BLOOD & CANCER (2008)
Impaired human hippocampal neurogenesis after treatment for central nervous system
Michelle L. Monje et al.
ANNALS OF NEUROLOGY (2007)
Loss of suppressor-of-fused function promotes tumorigenesis
Y. Lee et al.
ONCOGENE (2007)
Presentation of childhood CNS tumours: a systematic review 3 and meta-analysis
Sophie Wilne et al.
LANCET ONCOLOGY (2007)
Long-Term Impact of Radiation on the Stem Cell and Oligodendrocyte Precursors in the Brain
Georgia Panagiotakos et al.
PLOS ONE (2007)
Nodule formation and desmoplasia in medulloblastomas - Defining the nodular/desmoplastic variant and its biological behavior
Charles S. McManamy et al.
BRAIN PATHOLOGY (2007)
Dullard promotes degradation and dephosphorylation of BMP receptors and is required for neural induction
Reiko Satow et al.
DEVELOPMENTAL CELL (2006)
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis
Steven C. Clifford et al.
CELL CYCLE (2006)
A novel somatic mouse model to survey tumorigenic potential applied to the hedgehog pathway
Junhao Mao et al.
CANCER RESEARCH (2006)
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
Amar Gajjar et al.
LANCET ONCOLOGY (2006)
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma
Roger J. Packer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Genornics identifies medulloblastoma subgroups that are enriched for specific genetic alterations
MC Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells
CA Davis et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
White matter anisotropy in post-treatment childhood cancer survivors: Preliminary evidence of association with neurocognitive function
PL Khong et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
β-catenin status predicts a favorable outcome in childhood medulloblastoma:: The United Kingdom Children's Cancer Study Group Brain Tumour Committee
DW Ellison et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: A French Society of Pediatric Oncology study
V Oyharcabal-Bourden et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma
TG Oliver et al.
DEVELOPMENT (2005)
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone
S Rutkowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma
WH St Clair et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Change in neurocognitive functioning after treatment with cranial radiation in childhood
BJ Spiegler et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Mechanisms of radiation injury to the central nervous system: implications for neuroprotection
CS Wong et al.
MOLECULAR INTERVENTIONS (2004)
Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome
L Distel et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2003)
Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas
CS McManamy et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology United Kingdom Children's Cancer Study Group PNET-3 study
RE Taylor et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Medulloblastoma tumorigenesis diverges from cerebellar granule cell differentiation in patched heterozygous mice
JYH Kim et al.
DEVELOPMENTAL BIOLOGY (2003)
Irradiation induces neural precursor-cell dysfunction
ML Monje et al.
NATURE MEDICINE (2002)
Mutations in SUFU predispose to medulloblastoma
MD Taylor et al.
NATURE GENETICS (2002)
Gli3 is not mutated commonly in sporadic medulloblastomas
A Erez et al.
CANCER (2002)
Prediction of central nervous system embryonal tumour outcome based on gene expression
SL Pomeroy et al.
NATURE (2002)
Histopathologic grading of medulloblastomas - A pediatric oncology group study
CG Eberhart et al.
CANCER (2002)
Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma : A children's cancer group study
MD Ris et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood:: Results of the German prospective randomized trial HIT '91
RD Kortmann et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Share Paper
